Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method, and to a corresponding device, for analyzing chemical or biological samples in which chemical or biological samples and/or targets (probes) are applied in the form of individual defined spots to an outer cylindrical jacket surface of a support, or are aliquoted in the form of fluid droplet into drill holeswhick are chased in the jacket surface of the support. The support is inserted into a recess in a retainer, which recess is essentially complementary to the cylindrical jacket surface, the samples and/or targets are acted upon by way of physical and/or chemical interactions, and the correspondingly modified spots are then analyzed. The present invention provides an analytical system which provides unambiguously defined reaction volumes, which is easy to standardize and which can be automated to a high degree.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The invention relates to a method of analyzing nucleic acid fragments, comprising the following steps: a) providing at least one mixture of nucleic acid fragments which have at least one recognition site for a restriction endonuclease cutting outside its recognition site, b) incubating at least a fraction of said mixture of nucleic acid fragments of step (a) with at least one restriction endonuclease whose cleavage site is located outside its recognition site, c) identifying one or more nucleotides of the cut nucleic acid fragments of (b) and, where appropriate, identifying further fragment-specific properties of said cut nucleic acid fragments of (b), said identification(s) being carried out simultaneously for a plurality of or for all nucleic acid fragments.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The invention relates to a method of detecting and analyzing protein interactions in a cell, which comprises the steps: d) provision of the activity of at least one enzyme from the group consisting of recombinases and proteases in the cell as a result of a protein interaction, e) continual generation of an active reporter protein in the cell in question as a result of the enzymic activity of step a) for a period of time which exceeds the duration of the protein interaction of step a), f) generation of a detection signal by the reporter proteins generated in b). The invention furthermore relates to reverse embodiments of the method above of detecting and analyzing protein interactions in a cell, with, as a result of the induced dissociation of a defined interaction between proteins, the activity of at least one enzyme from the group consisting of recombinases and proteases being provided in the cell and converted to a permanent detection signal of said cell.

Abstract: The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.